ELSA SANTELLANO: Open Payments
NPI 1952021545 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 20 payments from 10 companies in 2025. Trend: 2023 $461 · 2024 $436 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $60 |
| Lilly USA, LLC | 2 | $50 |
| Amgen Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $42 |
| Corcept Therapeutics | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: JARDIANCE, Ozempic, UBRELVY, OTEZLA, REPATHA, Korlym, REXULTI, MOUNJARO.
Industry payments across TX — which companies pay providers there.
